4//SEC Filing
Plavsic Mark 4
Accession 0000950170-25-022655
CIK 0001501796other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:31 PM ET
Size
4.8 KB
Accession
0000950170-25-022655
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-02-18$7.75/sh−2,151$16,670→ 209,456 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:31 PM ET
- Size
- 4.8 KB